Flip Gene Therapeutics Inc.
PrivateLast Round
Seed
Sep 3, 2026
Total Funding Raised
$676,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Flip Gene Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in September 2026.
Flip Gene Therapeutics Inc. is a biotechnology company developing inducible gene therapy platforms and in vivo immune-cell reprogramming therapies for chronic autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flip Gene Therapeutics Inc. Comparables
Compare Flip Gene Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synvivia | 70% |
For institutional investors. Book with your work email.
Flip Gene Therapeutics Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
$676K raised, led by Catapult Network.
For institutional investors. Book with your work email.
Flip Gene Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flip Gene Therapeutics Inc.'s valuation, stock price, and market status.
Is Flip Gene Therapeutics Inc. a public or private company?
Flip Gene Therapeutics Inc. is a private company.
What is the current stock price of Flip Gene Therapeutics Inc.?
Flip Gene Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Flip Gene Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flip Gene Therapeutics Inc. worth (valuation)?
Valuation information for Flip Gene Therapeutics Inc. is not publicly available.
Can I buy Flip Gene Therapeutics Inc. stock?
Flip Gene Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flip Gene Therapeutics Inc.'s last funding round?
Flip Gene Therapeutics Inc.'s most recent funding round was Seed on September 3, 2026.
Who are the main investors in Flip Gene Therapeutics Inc.?
Investor information for Flip Gene Therapeutics Inc. is not publicly disclosed.
Will Flip Gene Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Flip Gene Therapeutics Inc..
How can I track Flip Gene Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Flip Gene Therapeutics Inc.'s shares on secondary markets.